5-Fluorouracil Metabolic Pathway Genes Predict Recurrence Risk Following Adjuvant S-1 Therapy: Results of an Ancillary Analysis from a Phase III Trial of Resected Biliary Tract Cancer (JCOG1202A1). Shuichi Mitsunaga , Masafumi Ikeda , Shogo Nomura , Chigusa Morizane , Akiko Todaka , Naoto Yamamoto , Ken Kamata , Hiroo Yanagibashi , Nobumasa Mizuno , Yasuyuki Kawamoto , Kunihito Gotoh , Hirofumi Shirakawa , Naohiro Okano , Tatsuya Nomura , Kazunari Tanaka , Amane Takahashi , Shintaro Yagi , Koji Ohta , Yukiko Takayama , Haruo Miwa , Hiroaki Nagano , Yasushi Kojima , Terumasa Hisano , Munenori Tahara , Yasunaru Sakuma , Hiroyuki Arai , Ikuo Nakamura , Hiroshi Katayama , Masaru Konishi , Makoto Ueno , Hepatobiliary and Pancreatic Oncology Group of the Japan Clinical Oncology Group (JCOG‐HBPOG) Journal of hepato-biliary-pancreatic sciences（2024）
AI 理解论文
溯源树
样例
